Since Paclitaxel resistance in cancer cells is primarily attributed to its removal from cells by the transmembrane pump P-glycoprotein (P-gp), we wanted to determine if P-gp was also involved in the promotion of hMSC Paclitaxel resistance. The gene discussed is ABCB1; the disease is cancer.